DIF-3 |
| Catalog No.GC68979 |
DIF-3 promotes the degradation of GSK-3β and reduces the expression levels of cyclin D1 and c-Myc. It inhibits Wnt/β-catenin signaling pathway-related proteins in DLD-1 cells. DIF-3 has a strong anti-proliferative effect on human cervical cancer cell line HeLa by inducing cyclin D1 degradation and inhibiting cyclin D1 mRNA expression.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 113411-17-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for DIF-3
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for DIF-3
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *